{"id":2706,"date":"2026-10-02T13:26:28","date_gmt":"2026-10-02T11:26:28","guid":{"rendered":"https:\/\/okulistyka21.pl\/?p=2706"},"modified":"2026-10-02T13:27:41","modified_gmt":"2026-10-02T11:27:41","slug":"myopia-experience-andrzeja-grzybowskiego","status":"publish","type":"post","link":"https:\/\/okulistyka21.pl\/en\/2026\/10\/02\/myopia-experience-andrzeja-grzybowskiego\/","title":{"rendered":"Myopia experience Andrzeja Grzybowskiego"},"content":{"rendered":"
\n\t\t\t\t\t\t
\n\t\t\t\t\t\t\t
\n\t\t\t\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t
\n\t\t\t\t\t

Profesor Andrzej Grzybowski od wielu lat zajmuje si\u0119 zar\u00f3wno leczeniem klinicznym, jak i badaniami naukowymi nad kr\u00f3tkowzroczno\u015bci\u0105 u dzieci, \u0142\u0105cz\u0105c praktyczn\u0105 opiek\u0119 nad pacjentami z mi\u0119dzynarodowymi badaniami i rozwojem wytycznych. Od ponad 20 lat udziela konsultacji specjalistycznych w Poradni Okulistyki Dzieci\u0119cej, gdzie leczy\u0142 oko\u0142o 200 dzieci atropin\u0105 w celu kontroli kr\u00f3tkowzroczno\u015bci. Jego do\u015bwiadczenie kliniczne uzupe\u0142nia bogata praca naukowa dotycz\u0105ca epidemiologii kr\u00f3tkowzroczno\u015bci w Polsce i na \u015bwiecie, a tak\u017ce wsp\u00f3\u0142czesnych strategii leczenia.<\/p>

Profesor Grzybowski jest uznanym nauczycielem akademickim, kt\u00f3ry prowadzi\u0142 liczne wyk\u0142ady i kursy na temat patogenezy kr\u00f3tkowzroczno\u015bci i dost\u0119pnych metod leczenia zar\u00f3wno dla odbiorc\u00f3w krajowych, jak i mi\u0119dzynarodowych. Od 2019 roku jest cz\u0142onkiem Grupy Roboczej ds. Kontroli Kr\u00f3tkowzroczno\u015bci Ameryka\u0144skiej Akademii Okulistyki (AAO) i wsp\u00f3\u0142autorem rekomendacji Akademii z 2020 roku dotycz\u0105cych profilaktyki i leczenia kr\u00f3tkowzroczno\u015bci u dzieci. Bra\u0142 r\u00f3wnie\u017c udzia\u0142 w opracowaniu wytycznych Europejskiego Towarzystwa Okulistycznego (SOE) z 2021 roku dotycz\u0105cych leczenia kr\u00f3tkowzroczno\u015bci u dzieci.<\/p>

Aktywnie zaanga\u017cowany w dzia\u0142alno\u015b\u0107 towarzystw naukowych, zasiada w zarz\u0105dach najwa\u017cniejszych europejskich organizacji okulistycznych i regularnie organizuje sesje naukowe po\u015bwi\u0119cone kr\u00f3tkowzroczno\u015bci. W 2019 roku za\u0142o\u017cy\u0142 i nadal koordynuje Europejsk\u0105 Sie\u0107 Kontroli Kr\u00f3tkowzroczno\u015bci (European Myopia Network) oraz zorganizowa\u0142 pierwsze mi\u0119dzynarodowe warsztaty po\u015bwi\u0119cone leczeniu kr\u00f3tkowzroczno\u015bci w Polsce. Jest profesorem okulistyki na Uniwersytecie Warmi\u0144sko-Mazurskim w Olsztynie i autorem ponad 900 recenzowanych publikacji. Ponadto jest g\u0142\u00f3wnym badaczem europejskiego projektu maj\u0105cego na celu opracowanie kalkulatora post\u0119pu kr\u00f3tkowzroczno\u015bci opartego na modelowaniu matematycznym i sztucznej inteligencji oraz europejskiego badania dotycz\u0105cego terapii \u015bwiat\u0142em czerwonym o niskim nat\u0119\u017ceniu w celu kontroli kr\u00f3tkowzroczno\u015bci.<\/p>

Artyku\u0142y prof. A. Grzybowskiego nt. kr\u00f3tkowzroczno\u015bci<\/h2>
  1. Morgan IA, Iribarren R, Fotouhi A, Grzybowski A. Cycloplegic refraction is the gold standard for epidemiological studies. Acta Ophthalmologica 2015;93(6):581-585.<\/li>
  2. Grzybowski A, Armesto A, Szwajkowska M, Iribarren G, Iribarren R. The Role of Atropine Eye Drops in Myopia Control. Curr Pharm Des. 2015;21(32):4718-30.<\/li>
  3. Grzybowski A. Other strategies of myopia control. Acta Ophthalmologica 2018;96 doi: 10.1111\/aos.13972_174.<\/li>
  4. Grzybowski A., Sobolewska B. Dobrowolsky from St. Petersburg and Hosch from Basel reported improvement of myopia after atropine use in 1868 and 1871. Strabismus 2018 Mar;26(1):46 doi: 10.1080\/09273972.2017.1421675.<\/li>
  5. Grzybowski A., Kanclerz P. The standardized definition of high myopia. Graefe’s Archive for Clinical and Experimental Ophthalmology 2019 doi: 10.1007\/s00417-019-04397-w.<\/li>
  6. Grzybowski A., Nowak M. The review of refractive studies of non-adults in Poland. Acta Ophthalmologica 2018;96(6):e755-e756.<\/li>
  7. Grzybowski A., Kanclerz P., Tsubota K., Lanca C., Saw S.M. A review on the epidemiology of myopia in school children worldwide. BMC Ophthalmology 2020 doi: 10.1186\/s12886-019-1220-0.<\/li>
  8. Modjtahedi BS, Abbott RL, Fong DS, Lum F, Tan D; Task Force on Myopia. Reducing the Global Burden of Myopia by Delaying the Onset of Myopia and Reducing Myopic Progression in Children: the Academy's Task Force on Myopia. Ophthalmology. 2020 Dec 30:S0161-6420(20)31043-5. doi: 10.1016\/j.ophtha.2020.10.040.<\/li>
  9. N\u00e9meth J, Tapaszt\u00f3 B, Aclimandos WA, Kestelyn P, Jonas JB, De Faber JHN, Januleviciene I, Grzybowski A, Nagy ZZ, P\u00e4rssinen O, Guggenheim JA, Allen PM, Baraas RC, Saunders KJ, Flitcroft DI, Gray LS, Polling JR, Haarman AE, Tideman JWL, Wolffsohn JS, Wahl S, Mulder JA, Smirnova IY, Formenti M, Radhakrishnan H, Resnikoff S. Update and guidance on management of myopia. European Society of Ophthalmology in cooperation with International Myopia Institute. Eur J Ophthalmol. 2021 Mar 5:1120672121998960. doi: 10.1177\/1120672121998960.<\/li>
  10. Pablo J Franco, Alejandro Suwezda, Patricio Schlottmann, Mar\u00eda P\u00eda Destefanis, Ruth E Rosenstein, Rafael Iribarren, Andrzej Grzybowski. Analysis of visual disability in Buenos Aires, Argentina. Pathologic myopia is the leading cause in working age, MEDICINA (Buenos Aires) 2021; 81: 735-741.<\/li>
  11. Shi-Ming Li, Ming-Yang Ren, Jiahe Gan, San-Guo Zhang, Meng-Tian Kang, He Li, David A. Atchison, Jos Rozema, Andrzej Grzybowski, Ningli Wang. Machine Learning to Determine Risk Factors for Myopia Progression in Primary School Children: The Anyang Childhood Eye Study. Ophthalmol Ther 2022 Jan 21. doi: 10.1007\/s40123-021-00450-2.<\/li>
  12. Dandan Ma, Shifei Wei, Shi-Ming Li, Xiaohui Yang, Kai Cao, Jianping Hu, Xiaoxia Peng, Ruohua Yan, Jing Fu, Andrzej Grzybowski, Zi-Bing Jin, and Ningli Wang. The Impact of Study-at-Home During the COVID-19 Pandemic on Myopia Progression in Chinese Children. Front. Public Health, 06 January 2022. https:\/\/doi.org\/10.3389\/fpubh.2021.720514<\/a> IF 3.709.<\/li>
  13. Iribarren R, Grzybowski A and Lanca C (2022) Editorial: Myopia: Public health challenges and interventions. Front. Public Health 10:1008858. doi: 10.3389\/fpubh.2022.1008858.<\/li>
  14. Lanca C., Grzybowski A. Topical Review: Studies on Management of Myopia Progression from 2019 to 2021. Optometry & Vision Science 2022 (in press).<\/li>
  15. Lanca C., Mehravaran S., Nordhausen K., Emamian M. H., Grzybowski A. Comment on: Development and validation of a novel nomogram for predicting the occurrence of myopia in schoolchildren: A prospective cohort study. American Journal of Ophthalmology. DOI: 10.1016\/j.ajo.2022.09.021 (list do redakcji).<\/li>
  16. Fern\u00e1ndez I., Balsa A., Armesto A., Magnetto I., Szeps A., Iribarren L., Iribarren R., Grzybowski A. Outdoor exposure in children from Buenos Aires Province, Argentina. Archivos de la Sociedad Espanola de Oftalmologia 2022, 97 (7), s. 396-401. DOI: 10.1016\/j.oftal.2021.02.010.<\/li>
  17. Nemeth J., Aclimandos W. A., Tapaszto B., Jonas Jost B., Grzybowski A., Nagy Z. Z. The impact of the pandemic highlights the urgent need for myopia guidelines: The clinicians’ role. European Journal of Ophthalmology. DOI: 10.1177\/11206721221143008 (wst\u0119p, edytorial).<\/li>
  18. Lanca C., Emamian M. H., Wong Y. L., Hashemi H., Khabazkhoob M., Grzybowski A., Saw S-M., Fotouhi A. Three-year change in refractive error and its risk factors: results from the Shahroud School Children Eye Cohort Study. Eye 2022, s. 1-10. DOI: 10.1038\/s41433-022-02219-8 IF 4.456.<\/li>
  19. Limwattanayingyong J., Amornpetchsathaporn A., Chainakul M., Grzybowski A., Ruamviboonsuk P. The Association Between Environmental and Social Factors and Myopia: A Review of Evidence From COVID-19 Pandemic. Frontiers in Public Health 2022, 10, s. 1-10 DOI: 10.3389\/fpubh.2022.918182. IF 6.461.<\/li>
  20. Simonaviciute D., Grzybowski A., Lanca C., Pang C.P., Gelzinis A., Zemaitiene R. The Effectiveness and Tolerability of Atropine Eye Drops for Myopia Control in Non-Asian Regions, Journal of Clinical Medicine 2023, 12(6), 2314 DOI: 10.3390\/jcm12062314 IF 4.964.<\/li>
  21. Lanca C., Pang C. P., Grzybowski A. Effectiveness of myopia control interventions: A systematic review of 12 randomized control trials published between 2019 and 2021, Frontiers in Public Health Volume 11 – 2023 DOI: 10.3389\/fpubh.2023.1125000 IF 6.461.<\/li>
  22. Lanca C., Repka M. X., Grzybowski A. Topical Review: Studies on Management of Myopia Progression from 2019 to 2021, Optometry and Vision Science 2023, 100 (1), s. 23-30, DOI: 10.1097\/OPX.0000000000001947 IF 2.106.<\/li>
  23. Lanca C., Parssinen O., Mehravaran S., Nordhausen K., Emamian M.H., Grzybowski A. Comment on: Development and Validation of a Novel Nomogram for Predicting the Occurrence of Myopia in Schoolchildren: A Prospective Cohort Study. American Journal of Ophthalmology 2023, 246, s. 273-274, doi: 10.1016\/j.ajo.2022.09.021 IF 4.200.<\/li>
  24. Hashemi H., Khabazkhoob M., Azizi E., Iribarren R., Lanca C., Grzybowski A., Rozema J.J., Emamian M.H., Fotouhi A. Longitudinal changes in crystalline lens thickness and power in children aged 6-12 years old. Eye (London. 1987) 2023, s. 1-7 doi: 10.1038\/s41433-023-02882-5 IF 3.900.<\/li>
  25. Iribarren R., Cunha C., Kaymak H., Grzybowski A. Preservatives and pH in low-dose atropine formulations for clinical trials. Acta Ophthalmologica 2023, (preprint) doi: 10.1111\/aos.16604 IF 3.988.<\/li>
  26. Tapaszt\u00f3 B., Flitcroft D.I., Aclimandos W.A., Jonas J.B., De Faber J.H.N., Nagy Z.Z., Kestelyn P.G., Januleviciene I., Grzybowski A., Vidinova C.N., Guggenheim J.A., Polling J.R., Wolffsohn J.S., Tideman J.W.L., Allen P.M., Baraas R.C., Saunders K.J., McCullough S.J., Gray L.S., Wahl S., Smirnova I.Y., Formenti M., Radhakrishnan H., Resnikoff S., N\u00e9meth J.; SOE Myopia Consensus Group. Myopia management algorithm. Annexe to the article titled Update and guidance on management of myopia. European Society of Ophthalmology in cooperation with International Myopia Institute. European Journal of Ophthalmology 2023 (Online ahead of print) doi: 10.1177\/11206721231219532 IF 1.700.<\/li>
  27. Artiemjew P., Cybulski R., Emamian M., Grzybowski A., Jankowski A., Lanca C., Mehravaran S., M\u0142y\u0144ski M., Morawski C., Nordhausen K., P\u00e4rssinen O., Ropia, K. Predicting Children’s Myopia Risk: A Monte Carlo Approach to Compare the Performance of Machine Learning Models. In Proceedings of the 16th International Conference on Agents and Artificial Intelligence – Volume 3, ISBN 978-989-758-680-4, ISSN 2184-433X, pages 1092-1099.<\/li>
  28. Lanca C., Repka M. X., Grzybowski A. Myths in Myopia Epidemiology and Treatment. JAMA Ophthalmol. Published online April 4, 2024. doi: 10.1001\/jamaophthalmol.2024.0575 IF 6.700.<\/li>
  29. Liu M-X, Zhu K-Y, Li D-L, Dong X-X, Liang G., Grzybowski A., Pan C-W. Corneal Biomechanical Characteristics in Myopes and Emmetropes Measured by Corvis ST: A Meta-Analysis. American Journal of Ophthalmology Volume 264, August 2024, Pages 154-161 DOI: 10.1016\/j.ajo.2024.03.024 IF 4.200.<\/li>
  30. Eppenberger L.S., Grzybowski A., Schmetterer L., Ang M. Myopia Control: Are We Ready for an Evidence Based Approach? Ophthalmology and Therapy Published: 07 May 2024 DOI: 10.1007\/s40123-024-00951-w IF 3.400.<\/li>
  31. Simonaviciute D., Grzybowski A., Gelzinis A., Zemaitiene R. Efficacy and Safety of 0.03% Atropine Eye Drops in Controlling Myopia Progression: A One-Year Prospective Clinical Study. Journal of Clinical Medicine 2024, 13, 3218 DOI: 10.3390\/jcm13113218 IF 3.900.<\/li>
  32. Li D.L., Dong X.X., Yang J.L., Lanca C., Grzybowski A., Pan C.W. Lower indoor spatial frequency increases the risk of myopia in children. British Journal of Ophthalmology 2024 Aug 8:bjo-2024-325888. DOI: 10.1136\/bjo-2024-325888. IF 3.7.<\/li>
  33. Simonaviciute D., Gelzinis A., Kapitanovaite L., Grzybowski A., Zemaitiene R. Myopia Control in Caucasian Children with 0.01% Atropine Eye Drops: 1-Year Follow-Up Study. Medicina (Kaunas). 2024 Jun 21;60(7):1022. DOI: 10.3390\/medicina60071022 IF 2.4.<\/li>
  34. Lanca C., Pan C.W., Grzybowski A. Anti-myopia Spectacles: The Standard of Care in the Future? American Journal of Ophthalmology 2024 Jul;263:xi-xiii. DOI: 10.1016\/j.ajo.2024.02.027 IF 4.1.<\/li>
  35. Dong X.X., Xie J.Y., Li D.L., Dong Y., Zhang X.F., Lanca C., Grzybowski A., Pan C.W. Association of sleep traits with myopia in children and adolescents: A meta-analysis and Mendelian randomization study. Preventive Medicine 2024 Mar;180:107893. DOI: 10.1016\/j.ypmed.2024.107893 IF 4.3.<\/li>
  36. Dong X-X., Chen D-L., Chen H-M., Li D-L., Hu D-N., Lanca C., Grzybowski A., Pan C-W. DNA methylation biomarkers and myopia: a multi-omics study integrating GWAS, mQTL and eQTL data. Clinical Epigenetics (2024) 16:157 DOI: 10.1186\/s13148-024-01772-1 IF 4.8.<\/li><\/ol>

    Wyk\u0142ady na konferencjach naukowych<\/h2>
    1. Grzybowski A. Atropine use in childhood myopia treatment. EVER Meeting, Nice, 10-13.10.2012.<\/li>
    2. Grzybowski A. Atropine Treatment of Myopia. WCO 2016, Meksyk 05-09.02.2016.<\/li>
    3. Grzybowski A. Is it possible to stop progression of myopia. Koscon 2016 Udupi, Indie 18.11-20.11.2016.<\/li>
    4. Grzybowski A. Myopia Treatment: The Historical Perspective. APAO 2017 Singapore, 01.03-05.03.2017 r.<\/li>
    5. Grzybowski A. Effective non-surgical strategies to stop myopia progression. 17th EURETINA Congress 2017, Barcelona, Hiszpania, 07.09-10.09.2017.<\/li>
    6. Grzybowski A. Other strategies of Myopia control. European Association for Vision and Eye Research (EVER) 2018. Francja, Nicea 04.10-06.10.2018.<\/li>
    7. Grzybowski A. Myopia Control Update. 34th Asia-Pacific Academy of Ophthalmology Congress (APAO) 2019. Tajlandia, Bangkok 06.03-09.03.2019.<\/li>
    8. Grzybowski A. How to control the progression of myopia in 2019? XXV White Nights Ophthalmology Congress XV Congress of The Association Ophthalmologists 2019, Petersburg, Rusia 27.05-31.05.2019.<\/li>
    9. Grzybowski A. Atropine to prevent myopia progression. 19th EURETINA Congress 2019, Paris, France 05.09-08.09.2019.<\/li>
    10. Grzybowski A. Myopia control. Forum Ophthalmologicum Balticum 2019, Vilnius, Lithuania 23.08-24.08.2019.<\/li>
    11. Grzybowski A. History of concepts of myopia pathogenesis and treatment. European Association for Vision and Eye Research (EVER) 2019, Nice, France 17.10-19.10.2019.<\/li>
    12. Grzybowski A. The epidemiology of myopia in school children worldwide. European Association for Vision and Eye Research (EVER) 2019, Nice, France 17.10-19.10.2019.<\/li>
    13. Grzybowski A. Myopia control in 2019. IX Congress of Belarusian Ophthalmologists 2019. Minsk, Belarus, 13.12-14.12.2019.<\/li>
    14. Grzybowski A. Myopia control in 2020. Eurolam 2020, 17.09.2020.<\/li>
    15. Grzybowski A. Global Initiative in Early Intervention to Prevent Myopia Progression, American Academy of Ophthalmology 2020 Virtual, 13.11-15.11.2020.<\/li>
    16. Grzybowski A. New Approaches to the Prevention and Treatment of Myopia: Update 2020, American Academy of Ophthalmology 2020 Virtual, 13.11-15.11.2020.<\/li>
    17. Grzybowski A. How to prevent high myopia in 2020? Sao Paulo, Brazil, Dec 1-4, 2020.<\/li>
    18. Grzybowski A. Myopia control methods available in 2021, EURETINA 2021 Virtual, 9-12 September 2021.<\/li>
    19. Grzybowski A. Myopia control methods available in 2021. Euretina, Hamburg, 2022.<\/li>
    20. Grzybowski A. Jak zapobiega\u0107 wysokiej kr\u00f3tkowzroczno\u015bci w 2021 roku? KLOS 3-4.09.2021, Krak\u00f3w online.<\/li>
    21. Grzybowski A. Czy skazani jeste\u015bmy na epidemi\u0119 wysokiej kr\u00f3tkowzroczno\u015bci? III Mi\u0119dzynarodowa Konferencja Jaskrowo-Za\u0107mowa GlauCat, 27-28 sierpnia 2021, Miko\u0142ajki.<\/li>
    22. Grzybowski A. Pharmacological Interventions Webinar European Society of Ophthalmology (SOE) How to Prevent Myopia Onset and Reduce Myopia Progression? 26.11.2021.<\/li>
    23. Grzybowski A. New Approaches to the Prevention and Treatment of Myopia: Update 2021. American Academy of Ophthalmology (AAO), New Orleans, USA (12-15.12.2021).<\/li>
    24. Grzybowski A. The Future of High Miopia Riseand What We Can Do About It? Congresso de Oftalmologia USP – COUSP, Sao Paulo, Brazil 4.12.2021.<\/li>
    25. Grzybowski A. Myopia control: update 2021 XIV Republican Congress „Current Issues of Ophthalmology” 11.12.2021.<\/li>
    26. Grzybowski A. Benefits and limitations of low dose atropine. EVER 2022.<\/li>
    27. Grzybowski A. Epidemiology and risk factors for myopia development, EVER 2022.<\/li>
    28. Grzybowski A. Pharmacology of Myopia control, Case Reports in Ophthalmology Meeting 2022.<\/li>
    29. Grzybowski A. Pharmacological methods for myopia control. 2022 International Symposium of Ophthalmology (ISO) 2022, in celebration of the 20th anniversary of Joint Shantou International Eye Center, Shantou University & the Chinese University of Hong Kong, 10-11.12.2022.<\/li>
    30. Grzybowski A. Epidemiologia i farmakologiczne leczenie kr\u00f3tkowzroczno\u015bci. Zebranie Lubelskiego Oddzia\u0142u PTO, 9.03.2023.<\/li>
    31. Grzybowski A. Jak zapobiega\u0107 wysokiej kr\u00f3tkowzroczno\u015bci w 2023 roku?, IV edycja Sympozjum Siatk\u00f3wkowo-Jaskrowego \u201eOkulistyka Nowe Horyzonty\u201d \u0141\u00f3d\u017a 19-20 maja 2023.<\/li>
    32. Grzybowski A. How to prevent high myopia in 2023, Filatov Memorial Lectures 2023, Odessa 24-26 maja 2023.<\/li>
    33. Grzybowski A. The most recent developments in myopia control, SOE 2023 European Society of Ophthalmology, Praga 15-17 czerwca 2023.<\/li>
    34. Grzybowski A. Leczenie kr\u00f3tkowzroczno\u015bci w 2023 roku, Forum Okulistyki Dzieci\u0119cej i Strabologii, Warszawa 08-09 wrze\u015bnia 2023.<\/li>
    35. Grzybowski A. Myopia control in 2023, 15th Congress of Bulgarian Society of Ophthalmology \u201cLight Matters\u201d, Albena 28 wrze\u015bnia – 01 pa\u017adziernika 2023.<\/li>
    36. Grzybowski A. Pharmacology in the treatment of myopia, American Academy of Ophthalmology 2023, San Francisco 3-6 pa\u017adziernika 2023.<\/li>
    37. Grzybowski A. Myopia control methods available in 2023, 23rd Euretina Congress, Amsterdam 05-08 pa\u017adziernika 2023.<\/li>
    38. Grzybowski A. Mo\u017cliwo\u015bci hamowania progresji kr\u00f3tkowzroczno\u015bci w 2023 roku, III Og\u00f3lnopolski Zjazd Stowarzyszenia Chirurg\u00f3w Okulist\u00f3w Polskich, Jachranka 19-21 pa\u017adziernika 2023.<\/li>
    39. Grzybowski A. Benefits and limitations of the low dose atropine in the treatment of myopia, 26th EVER Congress, Walencja 26-28 pa\u017adziernika 2023.<\/li>
    40. Grzybowski A. How to avoid high myopia in 2023?, Annual Conference of Lithuanian Ophthalmological Society, Wilno 17-18 listopada 2023.<\/li>
    41. Grzybowski A. Myopia Epidemiology and Control in Europe in 2023, International Forum of Ophthalmology & Optometry, Shandong 17-19 listopada 2023.<\/li>
    42. Grzybowski A. How to Control Myopia in 2023 and Beyond, 50th Royal College of Ophthalmologists of Thailand (RCOPT) and the Thai Public Health Ophthalmology Society (TPHOS) Conference, Pattaya 29 listopada – 01 grudnia 2023.<\/li>
    43. Grzybowski. Epidemia kr\u00f3tkowzroczno\u015bci u dzieci, Podlaski Oddzia\u0142 Polskiego Towarzystwa Okulistycznego, Bia\u0142ystok 22 marca 2024.<\/li>
    44. A. Grzybowski. Myopia control: 2024 update, 2024 Filatov Memorial Lectures, 14th Annual Meeting of the Ukrainian Society of Ophthalmologists, Odesa 16-18 maja 2024.<\/li>
    45. Grzybowski. Innovations in myopia control in 2024, „Challenges in Ophthalmology”, Bu\u0142garia 16-19 maja 2024.<\/li>
    46. Grzybowski. Kr\u00f3tkowzroczno\u015b\u0107 – moda czy problem?, III Mi\u0119dzynarodowa Konferencja Szkoleniowa „Nowe Spojrzenie na Okulistyk\u0119”, Krak\u00f3w 16-19 maja 2024.<\/li>
    47. Grzybowski. Europejskie do\u015bwiadczenie z RLRL, Miopia 2024: Innowacje, Pozna\u0144 7 czerwca 2024.<\/li>
    48. Grzybowski. Innovations in Myopia control in children: Update 2024, 55 Zjazd Okulist\u00f3w Polskich, Lublin 13-15 czerwca 2024.<\/li>
    49. Grzybowski. Myopia control in 2024, 120th Anniversary Meeting of the Hungarian Ophthalmological Society, Eger, W\u0119gry 21-23 czerwca 2024.<\/li>
    50. Grzybowski. Basic Science Of Myopia, 5th World Congress of Paediatric Ophthalmology & Strabismus, Kuala Lumpur, Malezja 11-13 lipca 2024.<\/li>
    51. Grzybowski. RLRL: between known and unknown, 5th World Congress of Paediatric Ophthalmology & Strabismus, Kuala Lumpur, Malezja 11-13 lipca 2024.<\/li>
    52. A. Grzybowski. Myopia control methods: 2024 update, 24th EURETINA Congress, Barcelona, Hiszpania 19-22 wrze\u015bnia 2024.<\/li>
    53. B. Grzybowski. Dispelling Prevalent Misconceptions About Childhood Myopia, 27th EVER Congress, Walencja, Hiszpania 3-5 listopada 2024.<\/li>
    54. Grzybowski. RLRL in myopia control – European experience, 27th EVER Congress, Walencja, Hiszpania 3-5 listopada 2024.<\/li>
    55. Grzybowski. How to prevent high myopia in 2024, 58th National Congress of Turkish Ophthalmological Association, Turcja, 21-24 listopada 2024.<\/li>
    56. Grzybowski. How to avoid high myopia in 2024?, FLORetina\/ICOOR Meeting 2024 Faculty, Florencja, W\u0142ochy 5-8 grudnia 2024.<\/li>
    57. Grzybowski. Myopia control in 2024, Medical Contact Lens & Ocular Surface Association 2024 Annual Meeting, Londyn, Wielka Brytania 6 grudnia 2024.<\/li><\/ol>

      Kurs na konferencjach mi\u0119dzynarodowych<\/h2>